Skip to main content
Clinical Trials/JPRN-jRCT1062220049
JPRN-jRCT1062220049
Recruiting
Phase 2

Effects of a remote physical activity intervention for esophageal cancer patients undergoing neoadjuvant chemotherapy: a randomized controlled trial

oma Tomohiro0 sites58 target enrollmentAugust 20, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
oma Tomohiro
Enrollment
58
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 20, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
oma Tomohiro

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with esophageal cancer cStage 1\-4a (Union for International Cancer Control criteria) and undergoing preoperative chemotherapy
  • Male and female patients aged 20 years or older and 80 years or younger at the time of consent.
  • Two courses of three drugs (docetaxel, cisplatin, and fluorouracil) will be administered as neoadjuvant chemotherapy.

Exclusion Criteria

  • Diagnosed with dementia
  • Needs assistance in walking or moving around.
  • Patients undergoing treatment other than chemotherapy such as radiation therapy
  • Patients who are judged to be inappropriate as research subjects by the principal investigator and research coordinators.
  • Patients who are prohibited from exercise therapy by the attending physician due to complications such as serious cardiac or renal disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials